Hospital Pharmacy Europe - Adverse drug events,

Click here

Monday 20 May 2013 Register Login

You are here:

Suppliers Guide

New neurology product

Hospital Pharmacy Europe is assisting with a survey on messaging for a new neurology product. Click here

LATEST ISSUE

Contamination control and preparation of anticancer drugs, medicines reconciliation, Ruconest drug evaluation, ivacaftor for cystic fibrosis , oxycodone-naloxone prolonged-release tablets, IV chemotherapy, capsaicin in the treatment of severe neuropathic pain, alitretinoin in severe chronic hand eczema, Zyclara for actinic keratoses

Pharmacy Zone: Adverse drug events

Magazine	Sponsored content
News	Video

Page:

1

Mon 18 Jun
2012

Ineffective warnings blamed for adverse events
US researchers identify using eye-tracking technology an inability of many warnings to capture attention

Thu 8 Mar
2012

EMA good manufacturing collaboration expanded
Good manufacturing practice inspections to be extended to additional partners, including the WHO

Wed 7 Mar
2012

EMA publishes human drugs under evaluation
It lists all new human medicines under evaluation by the Committee for Medicinal Products for Human Use

Fri 2 Mar
2012

EAHP to attend EMA pharmacovigilance meet
The EMA will hold a stakeholder workshop to gauge views on EC Pharmacovigilance Directive

Thu 9 Feb
2012

Mediator® 'responsible' for thousands of deaths in France
Accusations force new law that substantially modifies the regulatory system for drugs in France

Thu 9 Feb
2012

Antidepressant use linked to hip surgery dissatisfaction
Understanding a patient's mental health status before hip surgery may improve education and care

Wed 8 Feb
2012

Computer order entry systems reduce drug events
Research suggests CPOEs are effective at reducing drug-related injury and harm

Tue 31 Jan
2012

Antipsychotic side-effects linked to genetics
Use of drugs may be associated with increased blood pressure and elevated blood sugar levels

Mon 30 Jan
2012

Prednisone 'unnecessary' after kidney transplant
Stopping immunosuppression soon after transplantation may prevent side-effects

Tue 24 Jan
2012

EMA suspends meprobamate-containing drugs
Gradual withdrawal period advised, after serious side-effects concluded to outweigh benefits

Tue 24 Jan
2012

EMA starts review of 'killer' MS drug Gilenya
Doctors advised to intensify cardiovascular monitoring after first dose, following death of patient

Fri 13 Jan
2012

Dabigatran linked to acute coronary event risk
Anticoagulant associated with increased risk of myocardial infarction or acute coronary syndrome

Wed 7 Dec
2011

Echocardiography 'can predict trastuzumab AEs'
Imaging technique hailed as effective evaluator of potential adverse effects of cancer drug

Wed 16 Nov
2011

Antidepressants linked to cardiac death
Combined use of antipsychotic and antidepressant drugs increases mortality risk during coronary event

Mon 14 Nov
2011

Side effects put men off breast cancer drug
Study shows male patients stop taking tamoxifen early because of drug-related side effects

Thu 3 Nov
2011

Hospital infection drugs 'can increase complications'
Risks of new antibiotic regimes must be considered, says study

Thu 20 Oct
2011

EAE to issue cardiac cancer therapy recommendations
Echocardiographic evaluation aimed at reducing adverse events of cancer therapies

Tue 20 Sep
2011

Nitric oxide 'beneficial for statin-induced myopathy'
Findings presented at European Society for Muscle Research Conference in Germany

Mon 22 Aug
2011

Antidepressant may cause abnormal heart rhythms
Celexa (citalopram hydrobromide) should be given as 40mg dose only, says FDA

Tue 16 Aug
2011

Effient® shows significant reduction in CV events
Effient® (Prasugrel) significantly reduces cardiovascular events compared to clopidogrel

Page:

1

Web design, hosting and programming by ModeZero